Current status:
Cancelled Post Market
Current status date:
1999-08-11
Product name:
ILOSONE LIQUID 125MG/5ML
DIN:
00015474
Electronic product monograph is not available
Company:
ELI LILLY CANADA INC
SUITE 900
Exchange Tower, 130 King Street West
Toronto
Ontario
Canada
M5X 1B1
Dosage form(s):
Suspension
Route(s) of administration:
Oral
Number of active ingredient(s):
1
Schedule(s):
Prescription
American Hospital Formulary Service (AHFS):
See footnote 3
08:12.12.04
Anatomical Therapeutic Chemical (ATC):
See footnote 4
J01FA01 ERYTHROMYCIN
List of active ingredient(s)
Active ingredient(s)
See footnote8
|
Strength |
ERYTHROMYCIN (ERYTHROMYCIN ESTOLATE)
|
125 MG / 5 ML
|